FI821252A0 - Omega-cyan-1, omega-difenyl-azaalkanderivat, deras framstaellning och dessa innehaollande laekemedel - Google Patents

Omega-cyan-1, omega-difenyl-azaalkanderivat, deras framstaellning och dessa innehaollande laekemedel

Info

Publication number
FI821252A0
FI821252A0 FI821252A FI821252A FI821252A0 FI 821252 A0 FI821252 A0 FI 821252A0 FI 821252 A FI821252 A FI 821252A FI 821252 A FI821252 A FI 821252A FI 821252 A0 FI821252 A0 FI 821252A0
Authority
FI
Finland
Prior art keywords
omega
azaalkanderivat
cyan
diphenyl
deras framstaellning
Prior art date
Application number
FI821252A
Other languages
English (en)
Other versions
FI76550C (fi
FI76550B (fi
FI821252L (fi
Inventor
Oskar Ehrmann
Manfred Raschack
Josef Gries
Rolf Kretzschmar
Hans Dieter Lehmann
Ludwig Friedrich
Dirk Wuppermann
Frank Zimmermann
Werner Seitz
Hans Joerg Treiber
Ferdinand Dengel
Wolfram Frank
Hans-Georg Kurbjuweit
Claus D Myller
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI821252A0 publication Critical patent/FI821252A0/fi
Publication of FI821252L publication Critical patent/FI821252L/fi
Application granted granted Critical
Publication of FI76550B publication Critical patent/FI76550B/fi
Publication of FI76550C publication Critical patent/FI76550C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
FI821252A 1981-04-10 1982-04-07 Foerfarande foer framstaellning av terapeutiskt anvaendbara omega-cyan-1, omega-difenyl-azaalkanderivat. FI76550C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3114497 1981-04-10
DE3114497 1981-04-10
DE3144150 1981-11-06
DE19813144150 DE3144150A1 (de) 1981-04-10 1981-11-06 (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Publications (4)

Publication Number Publication Date
FI821252A0 true FI821252A0 (fi) 1982-04-07
FI821252L FI821252L (fi) 1982-10-11
FI76550B FI76550B (fi) 1988-07-29
FI76550C FI76550C (fi) 1988-11-10

Family

ID=25792602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821252A FI76550C (fi) 1981-04-10 1982-04-07 Foerfarande foer framstaellning av terapeutiskt anvaendbara omega-cyan-1, omega-difenyl-azaalkanderivat.

Country Status (19)

Country Link
US (1) US4438131A (fi)
EP (1) EP0064158B1 (fi)
AU (1) AU546383B2 (fi)
CA (1) CA1184186A (fi)
CS (4) CS238635B2 (fi)
DD (1) DD201778A5 (fi)
DE (2) DE3144150A1 (fi)
DK (1) DK156513C (fi)
ES (4) ES8307210A1 (fi)
FI (1) FI76550C (fi)
GB (1) GB2100252B (fi)
GR (1) GR75531B (fi)
HU (1) HU186058B (fi)
IE (1) IE54044B1 (fi)
MX (1) MX9203501A (fi)
NO (1) NO152129C (fi)
PH (1) PH19739A (fi)
SG (1) SG78584G (fi)
SU (1) SU1308195A3 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3344755A1 (de) * 1983-12-10 1985-06-20 Basf Ag, 6700 Ludwigshafen 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate
US4612329A (en) * 1984-10-17 1986-09-16 Hokuriku Pharmaceutical Co., Ltd. Pharmaceutical alpha-aminoalkyl-alpha-alkylphenylacetonitriles
US4760089A (en) * 1985-09-09 1988-07-26 Smithkline Beckman Corporation Irreversible dopamine-β-hydroxylase inhibitors
FR2588258B1 (fr) * 1985-10-04 1989-12-15 Adir Nouveaux derives d'amino-5 valeronitrile, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
DE3535950A1 (de) * 1985-10-09 1987-04-09 Basf Ag Kombinationspraeparat
DE3535949A1 (de) * 1985-10-09 1987-04-09 Basf Ag Kombinationspraeparat
US4593042A (en) * 1985-10-18 1986-06-03 G. D. Searle & Co. Bicyclo-substituted phenylacetonitrile derivatives
FI86633C (fi) * 1985-10-18 1992-09-25 Searle & Co Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bicyklosubstituerade fenylacetonitrilderivat.
DE3542994A1 (de) * 1985-12-05 1987-06-11 Basf Ag Basisch substituierte phenylacetaldehyde, ihre herstellung und diese enthaltende arzneimittel
DE3603032A1 (de) * 1986-01-31 1987-08-06 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
CS258534B1 (en) * 1986-07-18 1988-08-16 Ludvik Blaha Derivatives of valeronitrile and method of their preparation
DE3634389A1 (de) * 1986-10-09 1988-04-21 Knoll Ag Verwendung von anipamil
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
ATE46439T1 (de) * 1986-12-13 1989-10-15 Basf Ag Kombinationspraeparat.
US5486539A (en) * 1989-12-21 1996-01-23 G. D. Searle & Co. Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
US5247119A (en) * 1990-12-12 1993-09-21 G. D. Searle & Co. Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
CS164891A3 (en) * 1991-05-31 1992-12-16 Vyzk Ustav Farm Biochem Sp N-arylalkyl derivatives of 2-aminomethyl-1,4-benzodioxan, and process forpreparing thereof
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
DE4234000A1 (de) * 1992-10-09 1994-04-14 Knoll Ag Verfahren zur Racemattrennung von Anipamil
PL2170050T3 (pl) 2007-06-20 2014-12-31 Milestone Pharmaceuticals Inc Krótkodziałające fenyloalkiloaminowe blokery kanału wapniowego i ich zastosowania
US9504747B2 (en) 2013-03-08 2016-11-29 Novartis Ag Lipids and lipid compositions for the delivery of active agents
BR112015021791B1 (pt) * 2013-03-08 2022-08-30 Novartis Ag Compostos de lipídio catiônico e composições de lipídios e farmacêuticas
EP4223285A3 (en) 2014-07-16 2023-11-22 Novartis AG Method of encapsulating a nucleic acid in a lipid nanoparticle host

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA916719A (en) 1972-12-12 Dengel Ferdinand Basically substituted phenylacetonitriles and method for their preparation
DE1154810B (de) 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE1643429A1 (de) * 1967-09-20 1971-01-28 Knoll Ag Basisch substituierte Phenylacetonitrile und Verfahren zu deren Herstellung
GB1202500A (en) 1967-12-08 1970-08-19 Knoll Ag Substituted phenylacetonitriles
GB1202750A (en) 1967-12-11 1970-08-19 Knoll Ag Substituted phenylacetonitriles
DE2059985C3 (de) 1970-12-05 1979-10-04 Knoll Ag, 6700 Ludwigshafen Rechtsdrehende, basisch substituierte Phenylacetonitrile, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2059923C3 (de) 1970-12-05 1979-01-25 Knoll Ag, 6700 Ludwigshafen l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE2946545A1 (de) * 1979-11-17 1981-05-27 Basf Ag, 6700 Ludwigshafen Verfahren zur gewinnung der enantiomeren formen von 4-cyan-1-(n-methyl-n-(2'-((3'',4'',-dimethoxyphenyl))-aethyl)-amino)-5-methyl-4-(3',4',5'-trimethoxyphenyl)-hexan und dessen salzen

Also Published As

Publication number Publication date
DD201778A5 (de) 1983-08-10
ES8402261A1 (es) 1984-01-16
FI76550C (fi) 1988-11-10
CS238635B2 (en) 1985-12-16
EP0064158A1 (de) 1982-11-10
DK156513C (da) 1990-02-05
IE54044B1 (en) 1989-05-24
CA1184186A (en) 1985-03-19
MX9203501A (es) 1992-09-01
ES8402560A1 (es) 1984-02-01
GB2100252A (en) 1982-12-22
DK159882A (da) 1982-10-11
CS238621B2 (en) 1985-12-16
ES8402262A1 (es) 1984-01-16
NO821085L (no) 1982-10-11
DK156513B (da) 1989-09-04
AU8249082A (en) 1983-04-21
EP0064158B1 (de) 1985-03-13
ES511260A0 (es) 1983-07-01
ES521544A0 (es) 1984-01-16
GR75531B (fi) 1984-07-26
IE820856L (en) 1982-10-10
SU1308195A3 (ru) 1987-04-30
CS238634B2 (en) 1985-12-16
HU186058B (en) 1985-05-28
ES521543A0 (es) 1984-02-01
FI76550B (fi) 1988-07-29
DE3262516D1 (en) 1985-04-18
DE3144150A1 (de) 1982-12-09
CS238636B2 (en) 1985-12-16
NO152129B (no) 1985-04-29
SG78584G (en) 1985-04-26
NO152129C (no) 1985-08-07
US4438131A (en) 1984-03-20
AU546383B2 (en) 1985-08-29
ES8307210A1 (es) 1983-07-01
PH19739A (en) 1986-06-23
FI821252L (fi) 1982-10-11
ES521545A0 (es) 1984-01-16
GB2100252B (en) 1984-06-27

Similar Documents

Publication Publication Date Title
FI833713A0 (fi) 1-fenyl-2-piperidino-propanol-derivat, deras framstaellning och dessa innehaollande laekemedel
FI821252L (fi) Omega-cyan-1, omega-difenyl-azaalkanderivat, deras framstaellning och dessa innehaollande laekemedel
FI823846A0 (fi) Nya bicykliska foereningar, foerfaranden foer deras framstaellning och dessa innehaollande farmaceutkompositioner
FI821724A0 (fi) Nya benzazepinderivat, deras framstaellning och deras anvaendning saosom laekemedel
FI822102L (fi) Rakkedjiga, basiska polymerisat, foerfarande foer deras framstaellning och deras anvaendning
FI821799A0 (fi) Cyklohexandionderivat, foerfarande foer deras framstaellning och dessa innehaollande herbicider
FI824267A0 (fi) Elektrisk stroemlist, i synnerhet uttagsskena foer starkstroemsdistribution, och haertill hoerande anslutningsdon
FI821962A0 (fi) Mandelsyraderivat och mandelonitriler, foerfaranden foer deras framstaellning och deras anvaendning bekaempning av mikro-organismer
FI821562L (fi) Kompatibelt, transkodbart och hierarkiskt digitalt televisionssystem
FI823022L (fi) Amino-organoaminosilaner, deras framstaellningsfoerfarande och deras anvaendning
FI821546A0 (fi) Aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
FI811705L (fi) Karbamoyloxiamino-1,4-benzodiazepiner foerfarande foer deras framstaellning och dessa innehaollande laekemedel
FI822549L (fi) Nya benztriazoler, deras framstaellning och deras anvaendning saosom laekemedel
FI820477L (fi) Amino-2,1,3-benzotiadiazol- och benzoxadiazolderivat deras framstaellning och dessa innehaollande laekemedel
FI823575A0 (fi) Anilinderivat, foerfarande foer deras framstaellning och hjaertmedicinkomposition
FI823910A0 (fi) Azolyl-penten-derivat, foerfaranden foer framstaellning av dessa foereningar och dessa innehaollandebiocider
FI824099L (fi) Hydroxialkylcellulosor med foerbaettrad stabilitet gentemot nedbrytning, deras framstaellningsfoerfarande och anvaendning
FI823982L (fi) Nya p-fenylendiaminer, deras framstaellning och anvaendning
FI821034L (fi) Pyridinderivat, deras framstaellning och anvaendning vid sjukvaord
FI821332L (fi) Pyrazolpyridinderivat och deras framstaellning, anvaendbara som hjaertlaekemedel
FI822802L (fi) Nya ditiol-1,2-yliden-3-ammoniumderivat, deras framstaellning och dessa innehaollande laekemedel
FI853426A0 (fi) Kancermotverkande platina-kroneterkomplex och laekemedel innehaollande dessa.
FI822550A0 (fi) Sulfiminer, deras salter och framstaellning samt dessa foereningar innehaollande laekemedel
FI844302L (fi) Nya purinderivat, deras framstaellning och dessa innehaollande laekemedel.
FI830794L (fi) Ytbundet, digitaliskt, kapasitivt informationsminne och foerfarande foer avlaesning och omkodning adetsamma

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BASF AKTIENGESELLSCHAFT